RxDoctor Payments Data

Johnnie Cyr

Family · El Centro, CANPI 1720673890

Payments from drug & device makers

$1,822in general payments, 2019–2025

Across 99 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$562
  • Amgen$205
  • Radius Health, Inc.$136
  • Bayer$108
  • Corcept Therapeutics$106
  • Novartis$100
  • plus $606 from 19 others

What the payments were for

  • Food & beverage$1,822100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,822 in reported general payments places this provider in the 80th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide198$186,999
JanuviaSitagliptin Phosphate52$40,211
RybelsusSemaglutide27$39,300
ProliaDenosumab22$35,880
CreonLipase/Protease/Amylase12$35,678
JardianceEmpagliflozin23$31,092
FarxigaDapagliflozin Propanediol37$24,251
VascepaIcosapent Ethyl58$23,011
MyrbetriqMirabegron38$19,221
EliquisApixaban25$17,883
Icosapent Ethyl56$16,384
Bydureon BciseExenatide Microspheres11$14,890
TrulicityDulaglutide15$14,526
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$11,538
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$10,885

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$38$226,299225 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$37$40,44967 claims
MerckJanuvia$14$40,21152 claims
Boehringer IngelheimJardiance, Tradjenta$37$39,03135 claims
AmgenProlia$205$35,88022 claims
AbbVieCreon$562$35,67812 claims
Astellas Pharma US IncMyrbetriq$24$19,22138 claims
PfizerEliquis$16$17,88325 claims
Lilly USA, LLCTrulicity$82$14,52615 claims
GSKTrelegy Ellipta$17$10,88515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,634 family providers in California.

Other family in El Centro

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →